Berkeley Lights launches optofluidic system Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select, its two-chip, single-cell optofluidic system for cell line development (CLD).Read More
Newly-discovered organelle key to sense of smell Sweden’s Umeå Universit said this week that its researchers have discovered a previously unknown component inside nerve cells—an organelle that enables the perception of smell. The discovery, published recently in Nature Communications, may have implications for research on olfactory impairment -- a common COVID-19 symptom.Read More
Blood test helps diagnose inaccessible brain tumors A prospective, blinded study by London’s Imperial College researchers showed the TriNetra-Glio liquid biopsy test, which requires 15 mL of blood, can detect malignant brain tumors.Read More
Immune surprise: alarm protein drives inflammation Trinity College scientists have discovered that a key immune alarm protein, previously believed to calm the immune response, actually does the opposite. The study, published December 16 in the journal Science Immunology, advances the understanding of autoimmune disorders and how inflammation is regulated.Read More
MinervaX announces funding for Group B Streptococcus vaccine Danish biotechnology company MinervaX ApS announced the completion of a 72-million-euro ($76.3 million) financing round to advance development of a novel vaccine against Group B Streptococcus (GBS). An equity financing of 22 million euros was co-led by new investors Trill Impact Ventures and Pureos Bioventures and existing investors. The European Investment Bank provided additional funding in a form of a 50-million-euro loan.Read More